|
|
PVCT Provectus Biopharmaceuticals
|
|
||
The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses
Noticed some of the updates at the end include, but are not limited to: Intratumoral Immunotherapy—Update 2019Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma |
return to message board, top of board |